Document is current
Any future updates will be listed below
-
Authors
Nissen, Michael J. http://orcid.org/0000-0002-6326-1764
Möller, Burkhard
Ciurea, Adrian
Mueller, Ruediger B.
Zueger, Patrick
Schulz, Martin
Ganz, Fabiana
Scherer, Almut
Papagiannoulis, Eleftherios
Hügle, Thomas
-
Funding
Funding for this research was provided by:
AbbVie
- License Information
-
More Information
Article History
Received: 19 November 2020
Accepted: 19 May 2021
First Online: 9 June 2021
Declarations
:
: Informed consent was obtained from all patients before inclusion in the SCQM registry and a regional ethics committee (CER-VD, 2019-00278) provided approval for collection of patient data from the SCQM cohort.
: Not applicable.
: <i>MN</i> has received consulting fees from AbbVie, Celgene, Eli Lilly, Novartis, and Pfizer.<i>AC</i> has received consulting and/or speaking fees from AbbVie, Celgene, MSD, Eli Lilly, Novartis, and Pfizer.<i>RM</i> has received honoraria and research support from AbbVie, Nordic, Pfizer, Janssen-Cilag, MSD, and Sanofi-Aventis.<i>PZ</i>, <i>MS</i>, and <i>FG</i> are employees of AbbVie Inc.<i>BM</i> has received honoraria from AbbVie, Celgene, Eli Lilly, Janssen-Cilag, Merck (MSD), Novartis, Pfizer, Roche, Sanofi-Aventis, and UCB.<i>AS</i> and <i>EP</i> have no conflicts to disclose.<i>TH</i> has received honoraria and research support from AbbVie, GSK, Eli Lilly, Novartis, Pfizer, Janssen-Cilag, MSD, and Sanofi-Aventis.
